Highlights

  • Revenue for H1 2026 rose around 17% year-on-year to approximately GBP 59 million.
  • Net debt stood at GBP 4.7 million, with GBP 8.3 million in cash.
  • Integration of recent acquisitions underway, expanding presence in the UK and Ireland.

Optima Health plc (LSE:OPT), a UK-based provider of technology-enabled corporate health and wellbeing services, announced its unaudited trading update for the half year ended 30 September 2025 (“H1 26”).

The Group recorded revenue of approximately GBP 59 million during the period, representing about 17% growth from GBP 50.8 million in H1 2025 and aligning with market expectations. Excluding leases, Optima reported a net debt position of GBP 4.7 million as of 30 September 2025, comprising a cash balance of GBP 8.3 million and total debt of GBP 13 million.

Contract Mobilisation and New Business Pipeline

During the period, Optima began mobilisation on its GBP 210 million contract to deliver medical assessment services to the UK Armed Forces. The Company also reported new business annualised wins of GBP 1.9 million, compared to GBP 3.6 million in H1 2025. Management noted that the pipeline of potential opportunities remains solid, supporting the company’s growth objectives.

Strategic Acquisitions and Expansion

Optima completed two acquisitions during H1 26 to expand its capabilities and geographic reach. In April 2025, the Company acquired Cognate Health Limited in Ireland for up to EUR 9 million—its first international acquisition. The business was rebranded as Optima Health Ireland in September 2025, strengthening its service offering across both the UK and Ireland.

In May 2025, Optima agreed to acquire Care first, a provider of Employee Assistance Programmes, from the Priory Group for a net consideration of GBP 15,000. The acquisition, which completed in June 2025, is expected to contribute approximately GBP 3.7 million in annual revenue. Integration of Care first into Optima’s core operations is ongoing.

Platform Enhancement and Outlook

Optima also initiated a programme to enhance its technology platform and improve operational efficiency. The programme includes investment in clinical and operational systems to support organic and inorganic growth, improve solution delivery, and enhance margins.

Management Commentary

Jonathan Thomas, Chief Executive Officer of Optima Health, said:

“We have achieved solid progress in the first half of the year, in line with our strategy, delivering growth year on year. The two strategic acquisitions that we completed in the first half have strengthened our UK footprint and marked our entry into our first international territory, expanding both our reach and capability. Looking ahead, we are confident that the quality of our solutions and platform, along with the targeted application of new technologies will enable us to capture further market share and reinforce our position as the UK's leading occupational health and wellbeing partner. Alongside this, we will maintain our disciplined approach of identifying and executing value enhancing M&A opportunities to accelerate growth. As mentioned at the full year results, the Board continue to believe we are well positioned for growth in FY 26.”

Share Performance

OPT’s shares traded at GBX 201.0 per share on 03 November 2025, up by 1.77% from its previous close of GBX 197.50.